We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NRBO market cap is 16.79M. The company's latest EPS is USD -2.5703 and P/E is -1.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.1M | -10.43M | -2.52M | -3.81M | -3.89M |
| Net Income | -3.11M | -4.68M | -2.6M | -734k | -3.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.18M | -29.72M | -15.3M | -19.63M | -15.89M |
| Net Income | -21.31M | -29.68M | -15.28M | -13.97M | -12.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.56M | 33.53M | 31.49M | 29.18M | 26.43M |
| Total Liabilities | 1.62M | 11.78M | 10.98M | 3.98M | 4.88M |
| Total Equity | 5.94M | 21.75M | 20.51M | 25.2M | 21.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.47M | 10.97M | 16.8M | 33.53M | 22.78M |
| Total Liabilities | 2.18M | 3.77M | 2.2M | 11.78M | 6.1M |
| Total Equity | 12.29M | 7.2M | 14.6M | 21.75M | 16.69M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.91M | -11.71M | -2.55M | -4.59M | -7.41M |
| Investing | 8k | 8k | -4k | -4k | -41k |
| Financing | -134k | 28.68M | N/A | -80k | -80k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.04M | -10.76M | -15.13M | -11.71M | -10.8M |
| Investing | -6.06M | 69k | -586k | 8k | -50k |
| Financing | 24.17M | 6.86M | 22.03M | 28.68M | -80k |
| Market Cap | 16.79M |
| Price to Earnings Ratio | -1.35 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.75 |
| Price to Book Ratio | 1.01 |
| Dividend Yield | - |
| Shares Outstanding | 4.85M |
| Average Volume (1 week) | 27.53k |
| Average Volume (1 Month) | 32.99k |
| 52 Week Change | -47.71% |
| 52 Week High | 6.7499 |
| 52 Week Low | 2.8888 |
| Spread (Intraday) | 0.23 (6.25%) |
| Company Name | NeuroBo Pharmaceuticals Inc |
| Address |
108 west 13th st wilmington, delaware 19801 |
| Website | https://www.neurobopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
